The number of redirected human breast cancer cell progeny was greater in those chimeras produced with CD44-enriched breast cancer cells; however this result may indicate that tumor-initiating breast cancer cells are more likely to be reprogrammed or alternatively that CD44 reprogrammed breast cancer cells are more likely to produce proliferatively active, reprogrammed progeny. Here, CD44 is linked to breast carcinoma.